Seroprevalence 36 Months after a Single-dose Bivalent Human Papillomavirus Vaccination among Nine to Fifteen-year-old Girls in Dhaka, Bangladesh: A Cross-sectional Study

2025/08/13 by Ashrafun Nessa, Md Foyjul Islam, Shirin Akhter Begum +5 · 1 voice
Medicine · #Cervical Cancer and HPV Research

paper · pdf · doi:10.14218/csp.2025.00008

openalex publication_date 2025/08/13 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31

Abstract

Immunization against human papillomavirus (HPV), particularly with a single-dose vaccine, offers a cost-effective strategy for cervical cancer prevention. This study aimed to evaluate the seroprevalence following a single-dose bivalent HPV vaccine among adolescent girls in Bangladesh and to examine its association with sociodemographic characteristics.

Discussions

• Single-dose bivalent HPV vaccination showed sustained seroprevalence 36 months post-shot in girls in Dhaka, Bangladesh. doi.org/10.14218/CSP... @elizabethjacobs.bsky.social @hpvfasterimplement.bsky.so [bsky, 1 points, 0 comments]

Related

• Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation
• Status of HPV disease and vaccination programmes in LMICs: Introduction to special issue
• HPV Vaccination for Male Adolescents?
• Acceptability of single-dose HPV vaccination schedule among health-care professionals in Kenya: a mixed-methods study
• Determinants and interventions for human papillomavirus vaccination uptake: protocol for an umbrella review of systematic reviews and meta-analyses